By www.reliablemarketforecast.com
Global And United States Rare Hemophilia Factors Market Report & Forecast 2023-2028 Story
89
$ 4350
Rare Hemophilia Factors Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Novo Nordisk
Biogen
Bayer healthcare
Pfizer, Inc.
Baxalta
CSL Behring
Bio Products Laboratory Ltd.